Expression of the ZEB1 (δEF1) transcription factor in human: Additional insights

Molecular and Cellular Biochemistry

Volumn 318, Issue 1-2, 2008, Pages 89-99

  Hurt, Elaine M ^a   Saykally, Jessica N ^b   Anose, Bynthia M ^c   Kalli, Kimberly R ^d   Sanders, Michel M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BETHEL UNIVERSITY   (United States)

^d Mayo Clinic   (United States)

Author keywords

EF1; Estrogen; Gynecologic carcinomas; TCF8; ZEB1

Indexed keywords

ESTROGEN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TCF8; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; HOMEODOMAIN PROTEIN; ZEB1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FETUS; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; NONHUMAN; OVARY CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA HYBRIDIZATION; RNA ISOLATION; CELL DIFFERENTIATION; DRUG EFFECT; ENDOMETRIUM TUMOR; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; FETUS; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; OVARIAN NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 54949147234     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9860-z     Document Type: Article

References (55)

1. Aigner K, Dampier B, Descovich L et al (2007) The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26:6979-6988. doi: 10.1038/sj.onc.1210508
2. Eger A, Aigner K, Sonderegger S et al (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24:2375-2385. doi: 10.1038/ sj.onc.1208429
3. Guaita S, Puig I, Franci C et al (2002) Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 expression and ZEB1 expression. J Biol Chem 277:39209-39216. doi: 10.1074/ jbc.M206400200
4. Chua HL, Bhat-Nakshari P, Clare SE et al (2007) NF-kB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2. Oncogene 26:711-724. doi: 10.1038/sj.onc.1209808
5. Liu Y, El-Naggar S, Darling DS et al (2008) Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135:579-588. doi: 10.1242/dev.007047
6. Spaderna S, Schmalhofer O, Wahlbuhl M et al (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68:537-544. doi: 10.1158/0008-5472.CAN-07-5682
7. Peinado H, Olmeda D, Cano A (2007) Snail, ZEB and bHLH factors in tumour progression: An alliance against the epithelial phenotype. Nat Rev Cancer 7:415-428. doi: 10.1038/nrc2131
8. Shirakihara T, Saitoh M, Miyazono K (2007) Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial-mesenchymal transition induced by TGF-β. Mol Biol Cell 18:3533-3544. doi: 10.1091/mbc.E07-03-0249
9. 2 induces transcriptional repressors ZEB1 and Snail in non-small cell lung cancer. Cancer Res 66:5338-5345. doi: 10.1158/0008-5472.CAN-05-3635
10. Kirschmann DA, Seftor EA, Nieva DRC et al (1999) Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat 55:127-136. doi: 10.1023/A:1006188129423
11. Pena C, Garcia JM, Silva J et al (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 14:3361-3370. doi: 10.1093/hmg/ddi366
12. Spoelstra NS, Manning NG, Higashi Y et al (2006) The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res 66:3893-3902. doi: 10.1158/0008-5472.CAN-05-2881
13. Krafchak CM, Pawar H, Moroi SE (2005) Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet 77:694-708. doi: 10.1086/497348
14. Liskova P, Tuft SJ, Gwilliam R et al (2007) Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy. Hum Mutat 28:638-643. doi: 10.1002/ humu.9495
15. Chamberlain EM, Sanders MM (1999) Identification of the novel player δEF1 in estrogen transcriptional cascades. Mol Cell Biol 19:3600-3606
16. Richer JK, Jacobsen BM, Manning NG et al (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218. doi: 10.1074/jbc.M110090200
17. Locklin RM, Riggs BL, Hicok KC et al (2001) Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using array technology. J Bone Miner Res 16:2192-2204. doi: 10.1359/ jbmr.2001.16.12.2192
18. Manavella PA, Roqueiro G, Darling DS et al (2007) The ZFHX1A gene is differentially autoregulated by its isoforms. Biochem Biophys Res Commun 360:621-626. doi: 10.1016/j.bbrc.2007.06.088
19. Liu Y, Costantino ME, Montoya-Durango D et al (2007) The zinc finger transcription factor ZFHX1A is linked to cell proliferation by Rb-E2F1. Biochem J 408:79-85. doi: 10.1042/BJ20070344
20. Funahashi J-I, Sekido R, Murai K (1993) δ-crystallin enhancer binding protein δ-EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. Development 119:433-446
21. Conover CA, Hartmann LC, Bradley S et al (1998) Biological characterization of human epithelial ovarian carcinoma cells in primary culture: The insulin-like growth factor system. Exp Cell Res 238:439-449. doi: 10.1006/excr.1997.3861
22. Mo B, Vendrov AE, Palomino WA et al (2006) ECC-1 cells: A well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium. Biol Reprod 75:387-394. doi: 10.1095/biolreprod.106.051870
23. Baldwin W, Curtis S, Cauthen C et al (1998) BG-1 ovarian cell line: An alternative model for examining estrogen-dependent growth in vitro. In Vitro Cell Dev Biol 34:649-654
24. Carney SA, Tahara H, Swartz CD et al (2002) Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: Molecular and phenotypic characteristics. Lab Invest 82:719-728. doi: 10.1097/01.LAB.0000017499.51216.3E
25. Palmer-Densmore M, Deachapunya C, Kannan M et al (2002) UTP-dependent inhibition of Na + absorption requires activation of PKC in endometrial epithelial cells. J Gen Physiol 120:897-906. doi: 10.1085/jgp. 20028608
26. Abal M, Planaguma J, Gil-Moreno A et al (2006) Molecular pathology of endometrial carcinoma: Transcriptional signature in endometrioid tumors. Histol Histopathol 21:197-204
27. van Grunsven LA, Taelman V, Michiels C et al (2006) δEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis. Dev Dyn 235:1491-1500. doi: 10.1002/dvdy.20727
28. Miyoshi T, Van De Putte T, Kondoh H (2006) Complementary expression pattern of zfhx1 genes Sip1 and δEF1 in the mouse embryo and their genetic interaction revealed by compound mutants. Dev Dyn 235:1941-1952. doi: 10.1002/dvdy.20799
29. Takagi T, Moribe H, Kondoh H (1998) δEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 125:21-31
30. Witta SE, Gemmill RM, Hirsch FR et al (2006) Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res 66:944-950. doi: 10.1158/0008-5472.CAN-05-1988
31. Wang J, Scully K, Zhu X et al (2007) Opposing LSD1 complexes function in developmental gene activation and repression programs. Nature 446:882-887. doi: 10.1038/nature05671
32. Hall JM, Korach KS (2003) Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 17:792-803. doi: 10.1210/me.2002-0438
33. Piatak M, Luk KC, Williams B et al (1993) Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14:70-81
34. Willey JC, Crawford EL, Jackson CM et al (1998) Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am J Respir Cell Mol Biol 19:6-17
35. Souaze F, Ntodou-Thome A, Tran CY et al (1996) Quantitative RT-PCR: limits and accuracy. Biotechniques 21:280-285
36. Shang Y (2006) Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 6:360-368. doi: 10.1038/ nrc1879
37. Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83:783-795. doi: 10.1111/j.0001-6349.2004.00550.x
38. Cappellen D, Diez Gil, de Medina S, Chopin D et al (1997) Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 14:3059-3066. doi: 10.1038/ sj.onc.1201154
39. Lax SF (2007) Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium. Pathology (Phila) 39:46-54
40. Mutter GL, Baak JPA, Fitzgerald JT (2001) Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 83:177-185. doi: 10.1006/ gyno.2001.6352
41. Williams TW, Moolten D, Burlein J et al (1991) Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 254:1791-1794. doi: 10.1126/science.1840704
42. Grooteclaes ML, Frisch SM (2000) Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19:3823-3828. doi: 10.1038/sj.onc.1203721
43. Spaderna S, Schmalhofer O, Hlubek F et al (2006) A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131:830-840. doi: 10.1053/ j.gastro.2006.06.016
44. Fontemaggi G, Gurtner A, Strano S et al (2001) The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol 21:8461-8470. doi: 10.1128/MCB.21.24.8461-8470.2001
45. Fontemaggi G, Gurtner A, Damalas A et al (2005) DeltaEF1 repressor controls selectively p53 members during differentiation. Oncogene 24:7273-7280. doi: 10.1038/sj.onc.1208891
46. Watanabe Y, Kawakami K, Hirayama Y et al (1993) Transcription factors positively and negatively regulating the Na, K-ATPase α1 subunit gene. J Biochem 114:849-855
47. Furusawa T, Moribe H, Kondoh H et al (1999) Identification of CtBP1 and CtBP2 as corepressors of zinc finger-homeodomain factor δEF1. Mol Cell Biol 19:8581-8590
48. Darling DS, Gaur NK, Zhu B (1998) A zinc finger homeodomain transcription factor binds specific thyroid hormone response elements. Mol Cell Endocrinol 139:25-35. doi: 10.1016/S0303-7207(98)00076-8
49. Nishimura G, Manabe I, Tsushima K et al (2006) δEF1 mediates TCF-β signaling in vascular smooth muscle cell differentiation. Dev Cell 11:93-104. doi: 10.1016/j.devcel.2006.05.011
50. Qazi HAR, Goyal S, Mellon JK et al (2008) ZEB1 function in bladder cancer. J Urol 179:757. doi: 10.1016/S0022-5347(08)60765-X
51. Qazi HAR, Goyal S, Mellon JK et al (2008) The function of ZEB1 in bladder cancer. J Urol 179:879. doi: 10.1016/S0022-5347(08)60765-X
52. Postigo AA, Dean DC (1999) Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol Cell Biol 19:7961-7971
53. Postigo AA, Sheppard AM, Mucenski ML et al (1997) c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB. EMBO J 16:3924-3934. doi: 10.1093/emboj/16.13.3924
54. Tashiro H, Blazes MS, Wu R et al (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57:3935-3940
55. Persson I (2000) Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 74:357-364. doi: 10.1016/S0960-0760(00)00113-8